Cancer Hospital of Jiangsu Province, Nanjing Medical University, China.
Clinical Laboratory Center of Jiangsu Province, Nanjing, Affiliated Hospital of Zhangjiagang City, Nanjing Medical University, China.
Breast Care (Basel). 2013 Aug;8(4):290-2. doi: 10.1159/000354250.
The inflammatory myofibroblastic tumor (IMT) is an uncommon low-risk lesion with only a few cases described in the literature.
Here, we report a unique case of an IMT coexisting with breast cancer. Modified radical mastectomy was performed, followed by TAC chemotherapy (taxotere, adriamycin and cyclophosphamide). At the 2-year follow-up, the patient continues to be disease free.
At the preoperative stage, definitive diagnoses of masses are extremely difficult; surgery is advised only after the diagnosis is confirmed by pathological examination.
炎性肌纤维母细胞瘤(IMT)是一种罕见的低风险病变,文献中仅有少数病例描述。
在此,我们报告了一例 IMT 与乳腺癌共存的独特病例。行改良根治性乳房切除术,随后给予 TAC 化疗(多西紫杉醇、阿霉素和环磷酰胺)。在 2 年随访时,患者无疾病继续存在。
在术前阶段,对肿块的明确诊断极其困难;只有在病理检查确诊后才建议手术。